- Home
- ACRE vs SMTI Comparison
ACRE vs SMTI Comparison
Compare ACRE & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRE
- SMTI
- Stock Information
- Founded
- ACRE 2011
- SMTI 1982
- Country
- ACRE United States
- SMTI United States
- Employees
- ACRE N/A
- SMTI N/A
- Industry
- ACRE Real Estate Investment Trusts
- SMTI Medical/Dental Instruments
- Sector
- ACRE Real Estate
- SMTI Health Care
- Exchange
- ACRE Nasdaq
- SMTI Nasdaq
- Market Cap
- ACRE 337.1M
- SMTI 288.2M
- IPO Year
- ACRE 2012
- SMTI N/A
- Fundamental
- Price
- ACRE $5.91
- SMTI $34.00
- Analyst Decision
- ACRE Hold
- SMTI Strong Buy
- Analyst Count
- ACRE 7
- SMTI 2
- Target Price
- ACRE $6.80
- SMTI $47.00
- AVG Volume (30 Days)
- ACRE 781.8K
- SMTI 28.9K
- Earning Date
- ACRE 02-20-2025
- SMTI 11-12-2024
- Dividend Yield
- ACRE 16.91%
- SMTI N/A
- EPS Growth
- ACRE N/A
- SMTI N/A
- EPS
- ACRE N/A
- SMTI N/A
- Revenue
- ACRE $39,423,000.00
- SMTI $78,056,873.00
- Revenue This Year
- ACRE N/A
- SMTI $30.48
- Revenue Next Year
- ACRE N/A
- SMTI $24.07
- P/E Ratio
- ACRE N/A
- SMTI N/A
- Revenue Growth
- ACRE N/A
- SMTI 24.66
- 52 Week Low
- ACRE $5.33
- SMTI $26.00
- 52 Week High
- ACRE $10.53
- SMTI $40.75
- Technical
- Relative Strength Index (RSI)
- ACRE 43.41
- SMTI 53.26
- Support Level
- ACRE $5.33
- SMTI $31.99
- Resistance Level
- ACRE $5.99
- SMTI $33.59
- Average True Range (ATR)
- ACRE 0.19
- SMTI 1.26
- MACD
- ACRE 0.03
- SMTI 0.11
- Stochastic Oscillator
- ACRE 65.34
- SMTI 72.75
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.